調查批次:CHT2014-10 | 檢體寄出日期:2014-10-01 | 報告回收截止日期:2014-10-08 | 回收份數:21 |
FT4 檢驗院際品管調查結果: | ||
2.歷次品管檢體 FT4 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 2 |
2 |
5 |
2.30 |
-0.56 |
-19.6 |
-2.4 |
-0.7 |
-81 |
1.16 |
-0.08 |
-6.5 |
-0.8 |
-0.6 |
-27 |
RH07b | RH07 | 6 |
2 |
3 |
3.27 |
0.41 |
14.3 |
1.8 |
0.6 |
59 |
1.30 |
0.06 |
4.8 |
0.6 |
1.1 |
20 |
RH14 | RH14 | 6 |
2 |
3 |
3.46 |
0.60 |
21.0 |
2.6 |
0.9 |
87 |
1.25 |
0.01 |
0.8 |
0.1 |
0.5 |
3 |
RH15 | RH15 | 6 |
2 |
5 |
2.25 |
-0.61 |
-21.3 |
-2.7 |
-0.8 |
-88 |
1.18 |
-0.06 |
-4.8 |
-0.6 |
-0.4 |
-20 |
CL009 | CL009 | 5 |
2 |
5 |
2.19 |
-0.67 |
-23.4 |
-2.9 |
-0.9 |
-97 |
1.14 |
-0.10 |
-8.1 |
-1.0 |
-0.9 |
-33 |
CL010 | CL010 | 2 |
2 |
6 |
3.11 |
0.25 |
8.7 |
1.1 |
0.4 |
36 |
1.33 |
0.09 |
7.3 |
0.9 |
1.5 |
30 |
CL012 | CL012 | 5 |
2 |
3 |
4.42 |
1.56 |
54.5 |
6.8 |
2.2 |
226 |
1.20 |
-0.04 |
-3.2 |
-0.4 |
-0.1 |
-13 |
CL013 | CL013 | 5 |
2 |
5 |
2.21 |
-0.65 |
-22.7 |
-2.8 |
-0.8 |
-94 |
1.24 |
0.00 |
0.0 |
0.0 |
0.4 |
0 |
CL015 | CL015 | 7 |
2 |
3 |
2.63 |
-0.23 |
-8.0 |
-1.0 |
-0.3 |
-33 |
1.11 |
-0.13 |
-10.5 |
-1.3 |
-1.3 |
-43 |
Median of RIA Group |
2.63 |
1.20 |
||||||||||||||
Range of RIA Group |
2.19 - 4.42 |
1.11 - 1.33 |
||||||||||||||
Robust mean of RIA Group |
2.81 ( n = 9 ) |
1.21 ( n = 9 ) |
||||||||||||||
Robust SD of RIA Group |
0.72 |
0.08 |
||||||||||||||
CV of RIA Group |
25.6% |
6.6% |
||||||||||||||
Median of European RIA Labs |
2.46 ( n = 103 ) |
1.17 ( n = 103 ) |
||||||||||||||
Range of European RIA Labs ( 16% - 84% ) |
2.24 - 2.84 |
1.04 - 1.42 |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 5 |
4 |
9 |
3.14 |
0.28 |
9.8 |
1.2 |
1.4 |
41 |
1.32 |
0.08 |
6.5 |
0.8 |
1.1 |
27 |
RH02c | RH02 | 5 |
4 |
1 |
2.12 |
-0.74 |
-25.9 |
-3.2 |
-1.4 |
-107 |
1.03 |
-0.21 |
-16.9 |
-2.1 |
-0.6 |
-70 |
RH06 | RH06 | 2 |
4 |
9 |
2.88 |
0.02 |
0.7 |
0.1 |
0.6 |
3 |
1.33 |
0.09 |
7.3 |
0.9 |
1.1 |
30 |
RH07a | RH07 | 2 |
4 |
2 |
2.70 |
-0.16 |
-5.6 |
-0.7 |
0.2 |
-23 |
0.99 |
-0.25 |
-20.2 |
-2.5 |
-0.9 |
-83 |
RH12 | RH12 | 2 |
4 |
2 |
2.54 |
-0.32 |
-11.2 |
-1.4 |
-0.3 |
-46 |
1.01 |
-0.23 |
-18.5 |
-2.3 |
-0.8 |
-77 |
RH19 | RH19 | 3 |
4 |
2 |
2.45 |
-0.41 |
-14.3 |
-1.8 |
-0.5 |
-59 |
0.96 |
-0.28 |
-22.6 |
-2.8 |
-1.1 |
-93 |
RH20 | RH20 | 5 |
4 |
7 |
2.67 |
-0.19 |
-6.6 |
-0.8 |
0.1 |
-28 |
1.22 |
-0.02 |
-1.6 |
-0.2 |
0.5 |
-7 |
CL005 | CL005 | 1 |
4 |
9 |
2.99 |
0.13 |
4.5 |
0.6 |
0.9 |
19 |
1.30 |
0.06 |
4.8 |
0.6 |
0.9 |
20 |
CL006a | CL006 | 7 |
4 |
7 |
2.60 |
-0.26 |
-9.1 |
-1.1 |
-0.1 |
-38 |
1.25 |
0.01 |
0.8 |
0.1 |
0.6 |
3 |
CL008 | CL008 | 7 |
4 |
2 |
2.47 |
-0.39 |
-13.6 |
-1.7 |
-0.5 |
-57 |
0.98 |
-0.26 |
-21.0 |
-2.6 |
-0.9 |
-87 |
CL011 | CL011 | 0 |
4 |
13 |
3.00 |
0.14 |
4.9 |
0.6 |
1.0 |
20 |
1.30 |
0.06 |
4.8 |
0.6 |
0.9 |
20 |
CL014b | CL014 | 6 |
4 |
1 |
2.14 |
-0.72 |
-25.2 |
-3.1 |
-1.4 |
-104 |
1.04 |
-0.20 |
-16.1 |
-2.0 |
-0.6 |
-67 |
Median of CLIA Group |
2.64 |
1.13 |
||||||||||||||
Range of CLIA Group |
2.12 - 3.14 |
0.96 - 1.33 |
||||||||||||||
Robust mean of CLIA Group |
2.64 ( n = 12 ) |
1.14 ( n = 12 ) |
||||||||||||||
Robust SD of CLIA Group |
0.37 |
0.17 |
||||||||||||||
CV of CLIA Group |
14.0% |
14.9% |
||||||||||||||
Median of European CLIA Labs |
2.93 ( n = 1026 ) |
1.24 ( n = 1026 ) |
||||||||||||||
Range of European CLIA Labs ( 16% - 84% ) |
2.22 - 3.14 |
1.01 - 1.34 |
||||||||||||||
Median of All Labs |
2.63 |
1.20 |
||||||||||||||
Range of All Labs |
2.12 - 4.42 |
0.96 - 1.33 |
||||||||||||||
Robust mean of All Labs |
2.69 ( n = 21 ) |
1.17 ( n = 21 ) |
||||||||||||||
Robust SD of All Labs |
0.48 |
0.14 |
||||||||||||||
CV of All Labs |
17.8% |
12.0%
|
||||||||||||||
Median of All European Labs ( Xa ) |
2.86 |
1.24 |
||||||||||||||
Range of All European Labs ( 16% - 84% ) |
2.24 - 3.14 |
1.01 - 1.34 |
||||||||||||||
Mean of All European Labs |
2.74 ( n = 1197 ) |
1.19 ( n = 1197 ) |
||||||||||||||
SD of All European Labs |
0.436 |
0.155 |
||||||||||||||
CV of All European Labs |
16.0% |
13.1% |
||||||||||||||
SD for proficiency
assessment ( σp ) |
0.229 |
0.099 |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Competitive-type ) |
2 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL013, CL015, |
Chemiluminescent Immunoassay ( Competitive-type ) |
4 |
RH01a, RH02c, RH06, RH07a, RH12, RH19, RH20, CL005, CL006a, CL008, CL011, CL014b, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, CL014b, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH07b, RH14, CL012, CL015, |
Immunotech |
5 |
RH01b, RH15, CL009, CL013, |
MP |
6 |
CL010, |
Siemens ADVIA Centaur |
7 |
RH20, CL006a, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 台北郵政 26-624 號信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2014-10-09